China Biopharma Dealmaking 2020 Review
While many parts of the world ground to a halt as they tried to deal with the global pandemic, China had more or less brought the situation under…
Tagged with China
2020’s Top 7 Biotech IPOs in Profile
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you profiles of the seven biggest biotech…
China: Sinopharm Vaccine Approval; Online Healthcare Boom; 51%…
The latest from Chinese pharma, including domestic regulatory approval for Sinopharm’s COVID-19 vaccine, how the country’s online…
Chinese Pharma Share Price Hit; Pfizer-LianBio Linkup; Novo’s…
The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of successful COVID-19 trial results from…
Top 7 Biotech IPOs in 2020
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you the seven biggest biotech IPOs this year.…
China: Hitgen Aims to Strengthen its “Innovation Foundation”…
PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the company’s focus on DNA-encoded chemical…
China: 2020’s Biggest Biotech IPO in Profile
RemeGen, a low-profile Chinese biotech company based in Yantai city in the coastal Shandong province, around nine hours by train from the bustling…
China: Green Valley Alzheimer’s Trial; Samsung Biologics…
A roundup of the latest from Chinese pharma, including Green Valley’s upcoming US trial for an Alzheimer’s drug inspired by algae; Samsung…
Four Cell & Gene Companies to Know in China
While cell and gene therapies are all the rage now, a little known fact is that the world’s first approved gene therapy actually came from a Chinese…
Edigene CEO on Gene Editing Biotech’s Ambitious Expansion Plans
Following a recent capital injection of USD 67 million, Chinese biotech EdiGene is set to advance its pipeline in gene editing treatments and…
Fosun Pharma Gearing Up to Bring mRNA COVID-19 Vaccine to China
The collaboration between BioNTech and Pfizer on a COVID-19 vaccine candidate based on mRNA technology continues apace, with hopes for an emergency…
China: The Pharma Deals Keep Coming
The latest from Chinese pharma, with dealmaking continuing apace. Featured this week are Zai Lab’s latest IPO listing in Hong Kong, InventisBio…
